GrantRover ↗

← Tüm fırsatlar

National Institutes of Health · ABD

Continuation of the Exceptional Longevity Data Management and Coordinating… (U24 Clinical Trial Not Allowed)

Full title in the source: Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)

Ön duyuru — 8 Şubat 2027 tarihinde açılması bekleniyor

Bu bir ön duyurudur: fon sağlayıcı fırsatı duyurdu ancak henüz başvuruya açık değil; yayınlanması yaklaşık 8 Şubat 2027 tarihinde bekleniyor, tahmini son tarih 8 Mayıs 2027. Uygun başvuru sahibi türleri (kaynakta): Native American tribal governments (Federally recognized), For profit organizations other than small businesses, State governments ve 12 diğer.

Son başvuru
Tahmini 8 Mayıs 2027 (henüz kesin değil)
Açılış
8 Şubat 2027
Hibe tutarı
Belirtilmemiş — resmi çağrıya bakın
Destek oranı
Zorunlu eş finansman belirtilmemiş; destek oranı belirtilmemiş
Eş finansman
Gerekli değil
Olası başvuru sahipleri
Kamu kurumları, KOBİ’ler / girişimler, Şirketler, Üniversiteler ve araştırma, Kâr amacı gütmeyenler Kaynak kategorilerinden veya program kurallarından; uygunluğa çağrı karar verir.
Fon sağlayıcı
National Institutes of Health
Referans
RFA-AG-27-004
Destek listesi (ABD)
93.866 Aging Research
Son kontrol
15 Kasım 2026

Resmi çağrıyı aç ↗

Resmi açıklamalar fon sağlayıcının dilindedir (çoğunlukla İngilizce); bu sayfadaki özet ve temel bilgiler Türkçedir.

Çağrı hakkında

The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) through a single U24 cooperative agreement award. The NOFO will be open to all eligible applicants.

Established in 2022, the EL DMCC serves as the central hub for NIA’s human longevity translational research portfolio, integrating data and activities across studies to maximize the value of deeply phenotyped cohorts and associated genomic and multi-omics datasets.

The DMCC currently plays a critical role in enabling cross-cohort analyses, coordinating collaborative research, and advancing shared data resources. Core functions include data harmonization and integration; development and implementation of common data standards; provision of statistical, computational, and artificial intelligence and machine learning (AI/ML) infrastructure and tools; coordination of cross-project collaborations; and managing shared data systems, including data storage, access, and platform operations.

Tam metni oku

The DMCC also develops and maintains the ELITE (Exceptional Longevity Translational Resources) Portal, which provides secure access to harmonized datasets, analytical tools, and cloud-based computational workspaces. The DMCC supports controlled access to EL data and use of these resources by the research community and maintains ongoing efforts to ensure the Portal is interoperable with the NIA Alzheimer’s Disease Knowledge Portal and other data resources of the National Institutes of Health, consistent with FAIR (Findable, Accessible, Interoperable, Reusable) data principles.

Through the NOFO, the Coordinating Center will be expected to build on and expand these core functions by:

• Enhancing integration of increasingly large and diverse datasets across cohorts and species

• Expanding statistical, computational, and AI/ML capabilities and associated infrastructure

• Developing and refining methods and standards for multi-omics data harmonization and integrative analyses

• Coordinating and supporting collaborative research across NIA-funded projects

• Developing and disseminating translational resources, including target nomination and prioritization resources, curated target knowledgebases, and inventories of candidate therapeutic targets

• Advancing the ELITE Portal, including improvements in data organization, search, visualization, interoperability, and cloud-based analytical environments

• Strengthening community engagement through training, workshops, and collaborative activities

Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

Kimler başvurabilir

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Konular

Health

Nasıl başvurulur

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

İletişim

NIA Scientific Contact · NIA-NOFO-Scientific@nih.gov · Please contact via e-mail

Resmi kaynaklar

Resmi çağrı sayfası

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 15 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.

National Institutes of Health: diğer çağrılar

National Institutes of Health ABD

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High… (R34 Clinical Trial Required)

PAR-25-274

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychologic…

National Institutes of Health ABD

Investigator Initiated Clinical Trials of Complementary and Integrative… (R01 Clinical Trial Required)

PAR-25-268

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy…

National Institutes of Health ABD

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

PAR-25-267

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical…

National Institutes of Health ABD

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The inten…